NASDAQ:SNGX
Soligenix, Inc Stock News
$0.405
+0 (+0%)
At Close: May 03, 2024
Lookout for Price Target? Soligenix, Inc. (NASDAQ:SNGX), Fury Gold Mines Limited (AMEX:FURY)
01:11am, Monday, 13'th Dec 2021 Stock Equity
Soligenix, Inc. (NASDAQ:SNGX) with the stream of -2.09% also noticed, India Fury Gold Mines Limited (AMEX:FURY) encountered a rapid change of -3.05% in the last hour of Fridays trading session. The post Lookout for Price Target? Soligenix, Inc. (NASDAQ:SNGX), Fury Gold Mines Limited (AMEX:FURY) appeared first on Stocks Equity .
Hesitation to buy this Stock might leave you disappointed: Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), Soligenix, Inc. (NASDAQ:SNGX)
10:15am, Saturday, 04'th Dec 2021 Stock Equity
Sonnet BioTherapeutics Holdings, Inc. (SONN) with the stream of -10.85% also noticed, India Soligenix, Inc. (SNGX) encountered a rapid change of 2.54% in the last hour of Fridays trading session. The post Hesitation to buy this Stock might leave you disappointed: Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .
Soligenix reports 100% protection using a bivalent thermostabilized filovirus vaccine
01:01pm, Thursday, 02'nd Dec 2021 Seeking AlphaRevenue Approximations Analysis: AMC Entertainment Holdings, Inc. (NYSE:AMC), Soligenix, Inc. (NASDAQ:SNGX)
01:08am, Saturday, 27'th Nov 2021 Stock Equity
AMC Entertainment Holdings, Inc. (AMC) with the stream of -3.24% also noticed, India Soligenix, Inc. (SNGX) encountered a rapid change of 3.23% in the last hour of Fridays trading session. The post Revenue Approximations Analysis: AMC Entertainment Holdings, Inc. (NYSE:AMC), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .
FY2021 EPS Estimates for Soligenix, Inc. Boosted by Analyst (NASDAQ:SNGX)
06:08am, Thursday, 25'th Nov 2021 Dakota Financial News
Soligenix, Inc. (NASDAQ:SNGX) Equities research analysts at Zacks Investment Research upped their FY2021 earnings estimates for shares of Soligenix in a research report issued to clients and investors on Monday, November 22nd. Zacks Investment Research analyst D. Bautz now anticipates that the biopharmaceutical company will post earnings of ($0.31) per share for the year, []
Comparable Company Analysis: Color Star Technology Co., Ltd. (NASDAQ:CSCW), Soligenix, Inc. (NASDAQ:SNGX)
04:08am, Monday, 22'nd Nov 2021 Stock Equity
Color Star Technology Co., Ltd. (CSCW) with the stream of -2.26% also noticed, India Soligenix, Inc. (SNGX) encountered a rapid change of 0.12% in the last hour of Fridays trading The post Comparable Company Analysis: Color Star Technology Co., Ltd. (NASDAQ:CSCW), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .
Soligenix To File US Application For Its Lymphoma Photodynamic Therapy In 2H 2022
04:36pm, Monday, 01'st Nov 2021
In an SEC filing, Soligenix Inc (NASDAQ: SNGX) disclosed that it cannot file its HyBryte marketing application in the U.S. in 1H of 2022. Citing COVID-19 related disruptions resulting in delays by
Highlights and Insights into Soligenix
08:30am, Wednesday, 13'th Oct 2021
Dr. Chris Schaber Discusses Soligenix HyBryte(TM) and Thermostabilized VaccinesNew York, New York--(Newsfile Corp. - October 13, 2021) - PCG Digital -- In a recent interview with Kristen Kluska, a bio
PRINCETON, N.J., Oct. 12, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
PRINCETON, N.J., Sept. 28, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
Soligenix Invited to Present at the Cantor Fitzgerald Global Healthcare Conference
07:30am, Monday, 27'th Sep 2021
PRINCETON, N.J., Sept. 27, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
Soligenix To Test Synthetic Hypericin In Psoriasis Patients
01:14pm, Thursday, 16'th Sep 2021
Soligenix Inc (NASDAQ: SNGX) says that following the validation of synthetic hypericin's biologic activity, the Company will be expanding the therapy under the research name SGX302 into psoriasis.
Soligenix to Advance Synthetic Hypericin Development in Psoriasis
08:22am, Thursday, 16'th Sep 2021
PRINCETON, N.J., Sept. 16, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
SNGX Stock: The Big FDA News Giving Biotech Penny Stock Soligenix a Boost
01:46pm, Thursday, 09'th Sep 2021
Soligenix (SNGX) stock is roaring higher on Thursday thanks to some positive news from the U.S. Food and Drug Administration today. The post SNGX Stock: The Big FDA News Giving Biotech Penny Stock Sol
SNGX Stock: Why It Increased Today
10:50am, Thursday, 09'th Sep 2021
The stock price of Soligenix, Inc. (NASDAQ: SNGX) increased by more than 13% during intraday trading today. This is why it happened.